Your session is about to expire
← Back to Search
Vitamin D Supplement
Almond Milk with Vitamin D for Chronic Kidney Disease
N/A
Waitlist Available
Led By Jeanette Andrade, PhD
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 21 days
Awards & highlights
Study Summary
This trial is testing whether D3 in micro- and nanoparticles is effective in enhancing vitamin D status and reducing inflammation markers.
Eligible Conditions
- Chronic Kidney Failure
- Chronic Kidney Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 21 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~21 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Vitamin D
Secondary outcome measures
C-reactive protein
Calcium
IL-6
+3 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Based on estimated glomerular filtration rate (eGFR) and vitamin D levels, participants will be placed into the nanoparticle group.
Group II: ComparatorActive Control1 Intervention
Based on the estimated glomerular filtration rate (eGFR) and vitamin D levels, participants will be placed into the microparticle group.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
NanoD4CKD
2023
N/A
~30
Find a Location
Who is running the clinical trial?
University of FloridaLead Sponsor
1,340 Previous Clinical Trials
715,684 Total Patients Enrolled
Jeanette Andrade, PhDPrincipal InvestigatorUniversity of Florida
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have gastrointestinal (GI) disorders.You have problems with your stomach or digestion.You are allergic to almonds.You have special dietary needs for medical reasons.You have difficulty chewing or swallowing, as confirmed by a doctor.You do not have any problems or disruptions with your digestive system.
Research Study Groups:
This trial has the following groups:- Group 1: Comparator
- Group 2: Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is enrollment in this clinical trial still open?
"This research initiative, which was initially listed on October 1st 2022, is no longer recruiting. However, there are currently 539 other medical trials that require new volunteers."
Answered by AI
Share this study with friends
Copy Link
Messenger